Atlas Trials

Unresectable or Metastatic Melanoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable or Metastatic Melanoma

RecordFirmDate
Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma (NCT05783882)Biocad2022-02-01
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma (NCT04674683)HUYABIO International, LLC.2021-08-12
PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors (NCT03993379)CytomX Therapeutics2019-11-20
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma (NCT01810016)Ludwig Institute for Cancer Research2014-01-24
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) (NCT01844505)Bristol-Myers Squibb2013-06-11
A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) (NCT01721746)Bristol-Myers Squibb2012-12-21

Track Unresectable or Metastatic Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.